Shanghai Universal Biotech Co.,Ltd. (SHE:301166)

SHE:301166 Revenue

Shanghai Universal Biotech had revenue of 271.23M CNY in the quarter ending September 30, 2025, a decrease of -1.45%. This brings the company's revenue in the last twelve months to 1.07B, down -8.67% year-over-year. In the year 2024, Shanghai Universal Biotech had annual revenue of 1.12B, down -8.82%.

• Revenue (ttm): 1.07B
• Revenue Growth: -8.67%
• P/S Ratio: 2.68
• Revenue / Employee: 1.63M
• Employees: 698
• Market Cap: 2.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.12B	-108.07M	-8.82%
Dec 31, 2023	1.23B	30.70M	2.57%
Jan 1, 2023	1.20B	85.46M	7.70%
Jan 1, 2022	1.11B	260.59M	30.69%
Dec 31, 2020	849.08M	62.15M	7.90%